The Heart Foundation of Heartweek is on the 6th to 12th May.
The 2012 Influenza Vaccination Program will commence nationally on Thursday 15th March 2012
Children presenting to the emergency department with moderate or severe asthma attacks are less likely to be admitted to hospital if they are treated with systemic corticosteroids within the first 75 minutes after triage, according to a new study.
Central Queensland University conductes the largest Australian sleep census to explore the sleep habits of the nation. 
New research shows increased information and education regarding the neurocognitive, cardiovascular and metabolic consequences of untreated OSA, as well as the importance of persisting with the treatment has positive consequences on patients CPAP compliance.
New research results reinforce the value of follow-up tools following right heart catheterisation and provide further support for some of the treatment goals currently suggested by international guidelines.Optalert is an Australian business founded by sleep expert Dr Murray Johns who invented a personal safety device for transport workers to detect and prevent drowsy driving.
Drowsy driving
Drowsy driving is a factor in one in every six road accidents in Australia and one in three heavy vehicle accidents. The annual financial toll is estimated to be at least $2 billion in health and insurance costs in Australia and $56 billion in the U.S.
A 2001 survey by the Australian National Transport Commission found that at least 45 per cent of heavy vehicle drivers were impaired by fatigue during their last shift.
It found 52 per cent of major crash insurance claims were fatigue related. The survey also revealed 50 per cent of all long distance truck drivers had nodded off while driving more than once. According to the National Sleep Foundation’s 2005 Sleep in America poll, 60% of adult drivers have driven a vehicle while feeling drowsy in the past year, and more than one-third have actually fallen asleep at the wheel.
Fatigue monitoring systems
A number of vehicle manufactures are working on developing similar systems including Toyota, Volvo and Mercedes-Benz.
Optalert's system uses infra-red light to measures a driver’s levels of alertness continuously and objectively in real time. It is the first validated system that provides early warning signs of drowsiness. It includes a pair of glasses connected to a small computer processor in the vehicle. The glasses emit and detect low levels of infrared light to sense movements in the eyes and eyelids. These movements are fed into a computer that measures a driver's drowsiness and sounds an alarm as soon as the movements show the driver is becoming drowsy.
For more information click here.
Scientific validation
Optalert has been scientifically validated by Monash University Accident Research Centre (MUARC) to prove its accuracy and reliability.
Universities in Sweden and Professor Charles Czeisler from Harvard University Medical School are also running studies to validate the technology.
For more information click here.
Use
Optalert supplies transport and mining companies in Asia, Africa, South America and Australia including BHP Billiton, Toll Holdings, BIS Industries, Oz Minerals, WestNet Energy and Sutherland’s Transport.
Optalert Reports
The company recently launched a new service called Optalert Reports. It takes information from an onboard computer connected to a driver’s glasses to create an activity summary and travel log over a period of days or months. It can be used to identify potential risks and plan safe work schedules.
Awards
Optalert won an Australian Design Mark in the 2007 Australian Design Award It won the 2008 Victorian AIIA award for Industrial Applications. It was a finalist in the 4th Annual Australian Mining Prospect Awards.
Optalert also received a Bronze in the Industrial Designers Society of America (IDSA's) International Design Excellence Awards 2007, and was nominated in the INDEX: AWARD, 2007.